Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: Systematic review and meta-analysis

British Journal of Psychiatry

Volumn 207, Issue 4, 2015, Pages 293-298

  Orgeta, Vasiliki ^a   Qazi, Afifa ^b   Spector, Aimee ^a   Orrell, Martin ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NORTH EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c INSTITUTE OF MENTAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; CLINICAL PRACTICE; COGNITION; COGNITIVE THERAPY; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DSM-IV; EVIDENCE BASED PRACTICE; HUMAN; ICD-10; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; PATIENT COUNSELING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ANXIETY; COGNITIVE DEFECT; COUNSELING; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTHERAPY;

ANXIETY; COGNITIVE DYSFUNCTION; COGNITIVE THERAPY; COUNSELING; DEMENTIA; DEPRESSION; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84943764900     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.148130     Document Type: Review

References (44)

1. Enache D, Winblad B, Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 2011; 24: 461-72.
2. Weiner MF, Doody RS, Sairam R, Foster B, Liao TY. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dement Geriatr Cogn Disord 2002; 13: 8-12.
3. Palmer K, Berger AK, Monastero R, Winblad B, Bäckman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68: 1596-602.
4. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, et al. Incident occurrence of depressive symptoms among patients with mild cognitive impairment: the Italian longitudinal study on aging. Dement Geriatr Cogn Disord 2007; 24: 55-64.
5. Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 2000; 59: 97-106.
6. Lopez OL, Becker JT, Sweet RA. Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase 2005; 11: 65-71.
7. Ferreti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol 2001; 14: 52-8.
8. Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis 2009; 18: 11-30.
9. Gibbons LE, Teri L, Logsdon R, McCurry SM, Kukull W, Bowen J, et al. Anxiety symptoms as predictors of nursing home placement in patients with Alzheimer's disease. J Clin Geropsychol 2002; 8: 335-42.
10. Rozzini L, Chilovi BV, Peli M, Conti M, Rozzini R, Trabucchi M, et al. Anxiety symptoms in mild cognitive impairment. Int J Geriatr Psychiatry 2009; 24: 300-5.
11. Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, et al. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997; 9: 556-61.
12. Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 1997; 277: 806-12.
13. González-Salvador MT, Arango C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry 1999; 14: 701-10.
14. Schultz SK, Hoth A, Buckwalter K. Anxiety and impaired social function in the elderly. Ann Clin Psychiatry 2004; 16: 47-51.
15. Devanand DP, Pelton GH, Marston K, Camacho Y, Roose SP, Stern Y. Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 2003; 18: 123-30.
16. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL, et al. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 2009; 72: 2115-21.
17. Azermai M, Petrovic M, Elseviers MM, Bourgeois J, Van Bortel LM, Vander Stichele RH. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev 2012; 11: 78-86.
18. Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011; 378: 403-11.
19. Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 2003; 60: 737-46.
20. Petracca GM, Chemerinski E, Starkstein SE. A double-blind, placebocontrolled study of fluoxetine in depressed patients with Alzheimer's disease. Int Psychogeriatr 2001; 13: 233-40.
21. Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989; 146: 45-9.
22. Pinquart M, Sörensen S. How effective are psychotherapeutic and other psychosocial interventions with older adults? A meta-analysis. J Ment Health Aging 2001; 7: 207-43.
23. Wilson KC, Mottram PG, Vassilas CA. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008; 23: CD004853.
24. World Health Organization, Regional Office for Europe. Health Evidence Network, 2007 (http://www.euro.who.int/en/data-and-evidence/evidenceinformed-policy-making/health-evidence-network-hen).
25. Woods RT, Spector AE, Jones CA, Orrell M, Davies SP. Reminiscence therapy for dementia. Cochrane Database Systematic Rev 2009; 2: CD001120.
26. Gitlin LN, Winter L, Corcoran M, Dennis MP, Schinfeld S, Hauck WW. Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative. Gerontologist 2003; 43: 532-46.
27. Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, et al. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc 2007; 55: 158-65.
28. Orgeta V, Qazi A, Spector AE, Orrell M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev 2014; 1: CD009125.
29. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
30. Petersen RC. Conceptual Overview. In Mild Cognitive Impairment: Aging to Alzheimer's Disease (ed. RC Petersen): 1-14. Oxford University Press, 2003.
31. Visser PJ, Scheltens P, Verhey FR. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? J Neurol Neurosurg Psychiatry 2005; 76: 1348-54.
32. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In Systematic Reviews in Health Care: Meta-analysis in Context (eds M Egger, GD Smih, DG Altman): 285-312. BMJ Books, 2001.
33. Burgener SC, Yang Y, Gilbert R, Marsh-Yant S. The effects of a multimodal intervention on outcomes of persons with early-stage dementia. Am J Alzheimers Dis Other Demen 2008; 23: 382-94.
34. Burns A, Guthrie E, Marino-Francis F, Busby C, Morris J, Russell E, et al. Brief psychotherapy in Alzheimer's disease. Randomised controlled trial. Br J Psychiatry 2005; 187: 143-7.
35. Spector A, Orrell M, Lattimer M, Hoe J, King M, Harwood K, et al. Cognitive behavioural therapy (CBT) for anxiety in people with dementia: study protocol for a randomised controlled trial. Trials 2012; 13: 197.
36. Stanley MA, Calleo J, Bush AL, Wilson N, Snow AL, Kraus-Schuman C, et al. The peaceful mind program: a pilot test of a cognitive-behavioral therapy-based intervention for anxious patients with dementia. Am J Geriatr Psychiatry 2012; 21: 696-708.
37. Tappen RM, Williams CL. Therapeutic conversation to improve mood in nursing home residents with Alzheimer's disease. Res Gerontol Nurs 2009; 2: 267-75.
38. Waldorff FB, Buss DV, Eckermann A, Rasmussen ML, Keiding N, Rishj S, et al. Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY). BMJ 2012; 345: e4693.
39. Bains J, Birks J, Dening T. Antidepressants for treating depression in dementia. Cochrane Database Syst Rev 2002; 4: CD003944.
40. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011 (http://handbook.cochrane.org/).
41. Brodaty H, Arasaratnam C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry 2012; 169: 946-53.
42. Livingston G, Johnston K, Katona C, Paton J, Lyketsos CG. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005; 162: 1996-2021.
43. Olazarán J, Reisberg B, Clare L, Cruz I, Pen a-Casanova J, Del Ser T, et al. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 2010; 30: 161-78.
44. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996; 47: 113-24.